WO2001080619A3 - Pharmaceutical composition containing citalopram - Google Patents

Pharmaceutical composition containing citalopram Download PDF

Info

Publication number
WO2001080619A3
WO2001080619A3 PCT/DK2001/000520 DK0100520W WO0180619A3 WO 2001080619 A3 WO2001080619 A3 WO 2001080619A3 DK 0100520 W DK0100520 W DK 0100520W WO 0180619 A3 WO0180619 A3 WO 0180619A3
Authority
WO
WIPO (PCT)
Prior art keywords
citalopram
pharmaceutical composition
composition containing
containing citalopram
mixture
Prior art date
Application number
PCT/DK2001/000520
Other languages
French (fr)
Other versions
WO2001080619A2 (en
Inventor
Ken Liljegren
Per Holm
Ole Nielsen
Sven Wagner
Original Assignee
Lundbeck & Co As H
Ken Liljegren
Per Holm
Ole Nielsen
Sven Wagner
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26068858&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2001080619(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to NZ523785A priority Critical patent/NZ523785A/en
Priority to IL15405001A priority patent/IL154050A0/en
Priority to BR0113250-4A priority patent/BR0113250A/en
Priority to PL01359824A priority patent/PL359824A1/en
Priority to SK284-2003A priority patent/SK2842003A3/en
Priority to KR10-2003-7001683A priority patent/KR20030024833A/en
Priority to EA200300247A priority patent/EA200300247A1/en
Application filed by Lundbeck & Co As H, Ken Liljegren, Per Holm, Ole Nielsen, Sven Wagner filed Critical Lundbeck & Co As H
Priority to EP01957768A priority patent/EP1318805A2/en
Priority to JP2001577732A priority patent/JP2003531153A/en
Priority to AU2001279591A priority patent/AU2001279591A1/en
Priority to MXPA03000837A priority patent/MXPA03000837A/en
Publication of WO2001080619A2 publication Critical patent/WO2001080619A2/en
Publication of WO2001080619A3 publication Critical patent/WO2001080619A3/en
Priority to HR20030054A priority patent/HRP20030054A2/en
Priority to BG107578A priority patent/BG107578A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A solid unit dosage form comprising citalopram, which is prepared by direct compression of a mixture of citalopram base or a pharmaceutically acceptable salt thereof and pharmaceutically acceptable excipients, or by filling of said mixture in a hard gelatine capsule. Large crystals of a pharmaceutical acceptable salt of citalopram and method for the manufacture of said large crystals.
PCT/DK2001/000520 2000-08-10 2001-07-30 Pharmaceutical composition containing citalopram WO2001080619A2 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
MXPA03000837A MXPA03000837A (en) 2000-08-10 2001-07-30 Pharmaceutical composition containing citalopram.
EA200300247A EA200300247A1 (en) 2000-08-10 2001-07-30 PHARMACEUTICAL COMPOSITION CONTAINING CYTALOPRA
BR0113250-4A BR0113250A (en) 2000-08-10 2001-07-30 Solid dosage unit form; crystals of a pharmaceutically acceptable citalopram salt and method for manufacturing said crystals
PL01359824A PL359824A1 (en) 2000-08-10 2001-07-30 Pharmaceutical composition containing citalopram
EP01957768A EP1318805A2 (en) 2000-08-10 2001-07-30 Pharmaceutical composition containing citalopram
KR10-2003-7001683A KR20030024833A (en) 2000-08-10 2001-07-30 Pharmaceutical composition containing citalopram
IL15405001A IL154050A0 (en) 2000-08-10 2001-07-30 Pharmaceutical composition containing citalopram
NZ523785A NZ523785A (en) 2000-08-10 2001-07-30 Pharmaceutical composition containing citalopram and method to make crystals of the citalopram salt with a median particle size of at least 40 microns
SK284-2003A SK2842003A3 (en) 2000-08-10 2001-07-30 A solid unit dosage form comprising citalopram, crystals of a pharmaceutical acceptable salt of citalopram and method for the manufacture of said crystals
JP2001577732A JP2003531153A (en) 2000-08-10 2001-07-30 Pharmaceutical formulations containing citalopram
AU2001279591A AU2001279591A1 (en) 2000-08-10 2001-07-30 Pharmaceutical composition containing citalopram
HR20030054A HRP20030054A2 (en) 2000-08-10 2003-01-27 Pharmaceutical composition containing citalopram
BG107578A BG107578A (en) 2000-08-10 2003-02-21 Pharmaceutical composition containing citalopram

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200001202 2000-08-10
DKPA200001202 2000-08-10
DKPA200001614 2000-10-27
DKPA200001614 2000-10-27

Publications (2)

Publication Number Publication Date
WO2001080619A2 WO2001080619A2 (en) 2001-11-01
WO2001080619A3 true WO2001080619A3 (en) 2002-02-21

Family

ID=26068858

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK2001/000520 WO2001080619A2 (en) 2000-08-10 2001-07-30 Pharmaceutical composition containing citalopram

Country Status (34)

Country Link
EP (1) EP1318805A2 (en)
JP (1) JP2003531153A (en)
KR (1) KR20030024833A (en)
CN (1) CN1446089A (en)
AR (1) AR030095A1 (en)
AT (1) AT5744U1 (en)
AU (2) AU2001100198B4 (en)
BE (1) BE1013559A6 (en)
BG (1) BG107578A (en)
BR (1) BR0113250A (en)
CA (1) CA2353693C (en)
CH (2) CH694241A5 (en)
CZ (1) CZ2003397A3 (en)
DE (2) DE20113195U1 (en)
EA (1) EA200300247A1 (en)
ES (1) ES2172481B2 (en)
FI (1) FI5176U1 (en)
FR (1) FR2812811B1 (en)
GB (1) GB2368014B (en)
GR (1) GR1004193B (en)
HR (1) HRP20030054A2 (en)
HU (1) HUP0103071A3 (en)
IE (1) IES20010693A2 (en)
IL (1) IL154050A0 (en)
IS (1) IS6021A (en)
IT (1) ITMI20011637A1 (en)
MX (1) MXPA03000837A (en)
NL (1) NL1018741C1 (en)
NO (1) NO20013891L (en)
NZ (1) NZ523785A (en)
PL (1) PL359824A1 (en)
SK (1) SK2842003A3 (en)
WO (1) WO2001080619A2 (en)
YU (1) YU9003A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2353693C (en) * 2000-08-10 2003-07-22 H. Lundbeck A/S Pharmaceutical composition containing citalopram
AU2001100195B4 (en) * 2001-01-05 2001-12-20 H Lundbeck As Pharmaceutical composition containing citalopram.
GB0206708D0 (en) * 2002-03-21 2002-05-01 Cipla Ltd Pharmaceutical salts
MXPA05005772A (en) * 2002-12-23 2005-08-16 Lundbeck & Co As H Escitalopram hydrobromide and a method for the preparation thereof.
WO2004103361A2 (en) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited A pharmaceutical dosage form of citalopram
HU227491B1 (en) * 2003-11-25 2011-07-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Tablet containing citalopram hydrogen bromide
WO2006038217A1 (en) * 2004-10-05 2006-04-13 Strides Acrolab Limited An improved drug delivery system of citalopram hydrobromide and process for producing the same
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
CN100353939C (en) * 2006-01-05 2007-12-12 昆明积大制药有限公司 Antidepressant composition containing citalopram and cyclodextrin
GB2480192A (en) * 2007-02-02 2011-11-09 Ubiquisys Ltd Determining the location of a base station
CN106397249A (en) * 2015-08-03 2017-02-15 深圳信立泰药业股份有限公司 High-stability LCZ696 crystallized powder and a preparing method thereof
US20240100012A1 (en) * 2021-01-18 2024-03-28 Mark Hasleton Pharmaceutical dosage form

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1358915A (en) * 1971-09-13 1974-07-03 Merck & Co Inc Directly compressed tablet and composition therefor
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
EP0714663A2 (en) * 1994-11-28 1996-06-05 Eli Lilly And Company Potentiation of drug response by a serotonin 1A receptor antagonist
WO2001080619A2 (en) * 2000-08-10 2001-11-01 H. Lundbeck A/S Pharmaceutical composition containing citalopram

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1358915A (en) * 1919-04-14 1920-11-16 Amici Domenico Aeroplane
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
GB9714841D0 (en) * 1997-07-14 1997-09-17 Smithkline Beecham Plc Treatment method
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1358915A (en) * 1971-09-13 1974-07-03 Merck & Co Inc Directly compressed tablet and composition therefor
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
EP0714663A2 (en) * 1994-11-28 1996-06-05 Eli Lilly And Company Potentiation of drug response by a serotonin 1A receptor antagonist
WO2001080619A2 (en) * 2000-08-10 2001-11-01 H. Lundbeck A/S Pharmaceutical composition containing citalopram

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE CAPLUS [online] LILJEGREN KEN ET AL.: "Pharmaceutical compositions containing citalopram", XP002905400, accession no. STN Database accession no. 2001:797983 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide

Also Published As

Publication number Publication date
IES20010693A2 (en) 2002-07-10
CH694241A5 (en) 2004-10-15
EP1318805A2 (en) 2003-06-18
AT5744U1 (en) 2002-11-25
FI5176U1 (en) 2001-12-27
JP2003531153A (en) 2003-10-21
SK2842003A3 (en) 2003-09-11
CA2353693C (en) 2003-07-22
EA200300247A1 (en) 2003-06-26
IL154050A0 (en) 2003-07-31
FR2812811A1 (en) 2002-02-15
HUP0103071A2 (en) 2002-05-29
MXPA03000837A (en) 2003-06-06
FR2812811B1 (en) 2006-08-18
WO2001080619A2 (en) 2001-11-01
AU2001100198A4 (en) 2001-08-16
AU2001100198B4 (en) 2002-06-13
DE20113195U1 (en) 2001-11-15
NO20013891D0 (en) 2001-08-09
ES2172481A1 (en) 2002-09-16
GR20010100377A (en) 2002-09-06
PL359824A1 (en) 2004-09-06
CZ2003397A3 (en) 2003-06-18
GB2368014A (en) 2002-04-24
AU2001279591A1 (en) 2001-11-07
BE1013559A6 (en) 2002-03-05
KR20030024833A (en) 2003-03-26
AR030095A1 (en) 2003-08-13
CA2353693A1 (en) 2002-01-22
HU0103071D0 (en) 2001-10-28
NO20013891L (en) 2002-02-11
HRP20030054A2 (en) 2005-02-28
IS6021A (en) 2001-10-20
CH694242A5 (en) 2004-10-15
GR1004193B (en) 2003-03-24
GB2368014B (en) 2004-06-23
HUP0103071A3 (en) 2002-12-28
NZ523785A (en) 2004-09-24
GB0118579D0 (en) 2001-09-19
DE10139115A1 (en) 2002-03-28
BR0113250A (en) 2003-06-24
ES2172481B2 (en) 2004-08-01
NL1018741C1 (en) 2002-02-12
ITMI20011637A1 (en) 2003-01-27
ITMI20011637A0 (en) 2001-07-27
CN1446089A (en) 2003-10-01
BG107578A (en) 2003-09-30
YU9003A (en) 2006-05-25

Similar Documents

Publication Publication Date Title
CA2326517A1 (en) New galenic preparations of meloxicam for oral administration
WO2001080619A3 (en) Pharmaceutical composition containing citalopram
DE69620606D1 (en) FIXED ORAL APPLICATION FORM
CA2382098A1 (en) Sustained-release, oral pharmaceutical forms of administration
WO2007009806A3 (en) Solid dosage formulations of narcotic drugs having improved buccal adsorption
RU2003116058A (en) COMPOSITIONS OF A HYDROCODON WITH CONTROLLED RELEASE
AU6136199A (en) Dosage form comprising therapeutic formulation
WO2005065185A3 (en) Temperature-stable formulations, and methods of development thereof
CA2182004C (en) Film coated tablet of paracetamol and domperidone
HUP0301390A2 (en) Oral pharmaceutical composition containing valsartan
RU2003100507A (en) PHARMACEUTICAL COMPOSITIONS
EP1238662A3 (en) Method for manufacturing drug granules, the drug granules and pharmaceutical preparation containing the drug granules
WO2002024203A3 (en) Controlled release formulations for oral administration
NZ514129A (en) Tolperison-containing, pharmaceutical preparation for oral administration
MXPA03011317A (en) Swallow tablet comprising paracetamol.
WO2002015933A3 (en) Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
WO2004098577A3 (en) Dosage form containing (s)-pantoprazole as active ingredient
CA2432177A1 (en) Drug for prevention and/or therapy of endometriosis
JP2002538207A5 (en)
YU54503A (en) Pharmaceutical composition containing citalopram
WO2003101383A3 (en) Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
WO2005004836A3 (en) Saquinavir mesylate oral dosage form
RU2002126216A (en) PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF LIVER FIBROSIS AND CIRROSIS
HUP0401912A3 (en) Pharmaceutically acceptable salts of 20(s)-camptothecins, process for their preparation and pharmaceutical compositions containing them
PL355467A1 (en) Pharmaceutical composition for filling hard gelatine capsules, method of producing pharmaceutical composition for filling hard gelatine capsules and hard the hard gelatine capsules

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: P-90/03

Country of ref document: YU

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DE DK DK DM DZ EC EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DE DK DK DM DZ EC EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2001957768

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 154050

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2003/00561

Country of ref document: ZA

Ref document number: 200300561

Country of ref document: ZA

WWE Wipo information: entry into national phase

Ref document number: 523785

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: P20030054A

Country of ref document: HR

WWE Wipo information: entry into national phase

Ref document number: PA/a/2003/000837

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 018137520

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 1020037001683

Country of ref document: KR

Ref document number: 1020037001654

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 2001577732

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: PV2003-397

Country of ref document: CZ

Ref document number: 2001279591

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 10757801

Country of ref document: BG

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 200300247

Country of ref document: EA

WWE Wipo information: entry into national phase

Ref document number: 2842003

Country of ref document: SK

WWE Wipo information: entry into national phase

Ref document number: 1200300237

Country of ref document: VN

WWP Wipo information: published in national office

Ref document number: 1020037001683

Country of ref document: KR

WWR Wipo information: refused in national office

Ref document number: 1020037001654

Country of ref document: KR

WWW Wipo information: withdrawn in national office

Ref document number: 1020037001654

Country of ref document: KR

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2001957768

Country of ref document: EP

Ref document number: PV2003-397

Country of ref document: CZ

WWP Wipo information: published in national office

Ref document number: 523785

Country of ref document: NZ

WWG Wipo information: grant in national office

Ref document number: 523785

Country of ref document: NZ

WWW Wipo information: withdrawn in national office

Ref document number: 2001957768

Country of ref document: EP

WWR Wipo information: refused in national office

Ref document number: 1020037001683

Country of ref document: KR

WWR Wipo information: refused in national office

Ref document number: PV2003-397

Country of ref document: CZ